AGP Picks
View all

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on July 2, 2026

ITG, Inc. Announces Closing of Initial Public Offering
Important Notice to Long-Term Shareholders of First Solar, Inc. (NASDAQ: FSLR); Hub Group, Inc. (NASDAQ: HUBG); Navan, Inc. (NASDAQ: NAVN); and ZoomInfo Technologies, Inc. (NASDAQ: GTM): Grabar Law Office is Investigating Claims on Your Behalf
Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule
Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026
Pavilion Names Geoffrey Moore Keynote Speaker for GTM2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business First Bancshares, Inc. Schedules Q2 2026 Earnings Release and Conference Call for July 23
Monarch Casino & Resort To Report 2026 Second Quarter Results After Market Close On July 20
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Hub Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUBG
Halper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their Shareholders
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Robinhood Markets, Inc. to Announce Second Quarter 2026 Results on July 29, 2026
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
Rush Enterprises, Inc. Conference Call Advisory for Second Quarter 2026 Earnings Call
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Spyre Therapeutics Announces Grants of Inducement Awards
Patria Investments successfully raises over USD 670m for its Secondary Opportunities Fund V
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.